Q4 2017 13F Holders as of 31 Dec 2017
-
Type / Class
-
Equity / COMMON STOCK
-
Shares outstanding
-
236,833,431
-
Total 13F shares
-
17,028,282
-
Share change
-
+8,574,832
-
Total reported value
-
$54,659,000
-
Price per share
-
$3.21
-
Number of holders
-
23
-
Value change
-
+$27,531,551
-
Number of buys
-
19
-
Number of sells
-
6
Institutional Holders of ADMA BIOLOGICS, INC. - COMMON STOCK (ADMA) as of Q4 2017
As of 31 Dec 2017,
ADMA BIOLOGICS, INC. - COMMON STOCK (ADMA) was held by
23 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
17,028,282 shares.
The largest 10 holders included
PERCEPTIVE ADVISORS LLC, Aisling Capital LLC, Consonance Capital Management LP, Biomark Capital Management Co. LLC, Broadfin Capital, LLC, 683 Capital Management, LLC, Vanguard Group Inc, Iguana Healthcare Management, LLC, MORGENS WATERFALL VINTIADIS & CO INC, and HIGHBRIDGE CAPITAL MANAGEMENT LLC.
This page lists
23
institutional shareholders reporting positions in this security
for the Q4 2017 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.